What to Do When Medications and Therapy Aren’t Enough
Ritesha Krishnappa • December 29, 2025
Quick overview
When evidence-based talk therapy and medication management don’t bring sufficient relief, Elevium offers advanced, clinically proven options that can help many people regain function and hope:
- TMS (Transcranial Magnetic Stimulation) — a non-invasive, FDA-cleared brain-stimulation therapy for depression and certain other conditions.
- Spravato (esketamine) — an FDA-approved, rapidly acting medication for treatment-resistant depression given in-clinic under a REMS safety program.
- Ketamine (IV/IM/compounded intranasal/oral) — an off-label but increasingly used rapid-acting option with a different regulatory and coverage profile than Spravato.
Each has different mechanisms, logistics, evidence levels, and cost/coverage patterns. Below, we explain how they work, who they help, what to expect, and how Elevium integrates them into personalized care.
First step: careful re-evaluation
Before recommending an advanced therapy, Elevium begins with a comprehensive reassessment: review of diagnosis, co-occurring conditions (anxiety, PTSD, bipolar spectrum, substance use), medication history, prior psychotherapy responses, safety (including suicidal risk), medical history, and relevant labs or imaging. This ensures that the chosen option is medically appropriate and that reversible contributors (such as sleep, thyroid, substance, and medication interactions) have been addressed. Elevium’s medication-management and intake workflows emphasize this structured evaluation and shared decision-making.
TMS: how it helps when meds/therapy aren’t enough
How it works
TMS uses focused magnetic pulses to stimulate brain regions involved in mood regulation (commonly the left dorsolateral prefrontal cortex). It is a non-invasive procedure performed while the patient is awake. Evidence shows TMS can significantly reduce depressive symptoms in many patients who have not responded to multiple medication trials.
Who it’s for
- People with treatment-resistant depression (failed adequate trials of antidepressants) or those who can’t tolerate medication side effects.
- Selected patients with OCD or other indications, when supported by the device/protocol and clinical judgment. (Device-specific approvals and local practice guide candidacy.)
What the course looks like
- Intake & screening: psychiatric evaluation, medical history, and motor-threshold titration.
- Typical course: daily sessions (usually 5×/week) for ~4–6 weeks (about 20–30 sessions). Some accelerated protocols (e.g., iTBS) use much shorter sessions.
- During sessions, patients are awake, can read or relax, and usually resume normal activities afterward. Side effects are most commonly scalp discomfort or headache; seizures are rare with proper screening.
Why does it help when meds fail
TMS offers a non-systemic approach that targets neural circuits directly rather than changing neurotransmitter levels systemically. That means patients who did not respond to medication trials sometimes respond to TMS.
Pros/cons summary
- Pros: FDA-cleared, few systemic side effects, durable responses for many.
- Cons: Time commitment (daily visits), potential for scalp pain/headache, insurance often requires prior authorization and documentation of prior treatment failures.
Spravato (esketamine): a regulated, fast-acting option
How it works
Spravato is a nasal esketamine formulation that modulates glutamatergic signaling (NMDA receptor pathway) and can produce rapid antidepressant effects in patients with treatment-resistant depression. Because of safety risks (dissociation, sedation, blood pressure elevation), it is delivered in-clinic under a REMS program with post-dose monitoring.
Who it’s for
Patients who meet FDA-labeled criteria for treatment-resistant depression (typically after multiple failed antidepressant trials) require careful monitoring. Eligibility depends on clinical history and insurer criteria.
What the process looks like at a clinic
- Evaluation & documentation: psychiatric assessment and documentation of prior treatments to support prior authorization.
- Dosing visits: in-clinic dosing with at least 2 hours of observation after administration; vital signs and mental status are
- monitored until the patient is safe to leave.
- Follow-up: regular psychiatric follow-ups to assess response, side effects, and maintenance plans.
Why Spravato when meds fail
Spravato’s regulated, standardized dosing and FDA approval make it a clear option when conventional antidepressants fail, and a rapid response is desirable. Because it’s delivered under REMS, there is a well-defined safety and monitoring structure that many insurers recognize, which can improve the likelihood of coverage (though prior authorization is commonly required).
Pros/cons summary
- Pros: Rapid onset for many patients; FDA-approved pathway and standardized safety procedures.
- Cons: Must be administered and monitored in a clinic (time burden), dissociation and BP changes are possible, and insurance coverage requires documentation/PA.
Ketamine: flexible, rapid, but usually off-label
How it works
Generic ketamine (racemic) acts on glutamate signaling and can produce rapid antidepressant and anti-suicidal effects in many patients. It’s delivered in different forms (IV infusion is the most studied; IM and compounded intranasal/oral formulations are also used). Ketamine for depression is typically off-label, meaning the drug is not FDA-approved for depression specifically (unlike Spravato).
Who it’s for
Patients needing rapid symptom relief or those who have failed multiple conventional treatments. Because it is off-label, candidacy often requires careful informed consent and discussion of costs/coverage.
What a typical ketamine course looks like
- Screening & consent: medical review, substance-use screening, and informed consent for off-label use.
- Dosing: an acute series of infusions (for IV) over 1–2 weeks, followed by maintenance sessions as clinically indicated. Monitoring during and after dosing is routine to manage dissociation and blood-pressure changes.
- Integration: Many clinics recommend psychotherapy and functional support alongside ketamine to consolidate gains.
Why ketamine when meds fail
Ketamine’s speed of effect (sometimes hours to days) makes it an important option for crises or for patients who need quick symptom relief. However, the lack of standardized regulatory approval for depression means insurance coverage is inconsistent, and many patients pay out-of-pocket.
Pros/cons summary
- Pros: Rapid symptom relief for many, flexible administration routes.
- Cons: Off-label - variable insurance coverage; dissociation and transient BP changes; need for repeated maintenance and more research on long-term outcomes.
How Elevium chooses between these options
Decision factors we weigh
- Severity & urgency: suicidal ideation or severe impairment may favor rapid options (ketamine/Spravato under monitored conditions).
- Prior treatment history: number and adequacy of prior antidepressant/psychotherapy trials.
- Medical comorbidity & contraindications: seizure risk, cardiovascular issues, substance-use history, implants (for TMS).
- Logistics & preference: ability to attend daily TMS vs. preference for medication options; tolerance for clinic monitoring/time.
Insurance & cost: Spravato is often covered with prior authorization; ketamine is frequently self-pay; TMS coverage depends on the insurer and documentation. Elevium helps patients navigate benefits checks and prior authorizations.
Typical pathways
- TMS is often recommended when a patient has documented an inadequate response to medication and prefers a non-drug approach.
- Spravato is chosen when a patient meets labeled criteria and seeks a regulated, clinic-based rapid option.
- Ketamine may be offered when rapid relief is needed, and Spravato is not appropriate/available, with full discussion of cost and evidence.
Integration & ongoing care
Advanced treatments are rarely “one and done” — best outcomes come when these options are integrated with psychotherapy, medication management, and functional supports:
- Combine with psychotherapy: many patients do better when TMS/ketamine/Spravato are paired with ongoing evidence-based therapy to consolidate gains.
- Medication coordination: medication regimens may continue or be adjusted during/after advanced treatments. Elevium’s medication-management workflow supports close coordination.
- Maintenance planning: TMS maintenance schedules, Spravato maintenance dosing, or periodic ketamine sessions may be planned based on response.
Safety, monitoring, and practicalities
- TMS: requires pre-treatment screening for seizure risk and metal implants; most side effects are mild and transient.
- Spravato: administered under a REMS program with at least 2 hours of post-dose monitoring for dissociation/sedation and BP changes; prior authorization is routinely required.
- Ketamine: requires monitoring during infusion/dosing for dissociation and BP changes; because its use for depression is off-label, informed consent and careful follow-up are critical.
Insurance & cost realities
- TMS: many insurers cover TMS for treatment-resistant depression with prior authorization and proof of prior medication trials.
- Spravato: often covered when label criteria are met and REMS procedures are followed; still often requires PA.
- Ketamine: commonly considered investigational for depression by payers; many patients pay out-of-pocket.
Elevium helps by performing benefits checks, submitting prior authorizations, and estimating likely out-of-pocket costs.
How fast do these treatments work?
- TMS: many patients notice improvement after 2–4 weeks, with fuller benefit by the end of a standard course.
- Spravato: can act quickly (days to weeks) for many patients.
- Ketamine: often rapid, sometimes within hours to days. Response times vary.
Are these treatments safe?
All carry specific risks and require screening and monitoring. TMS has low systemic risk; Spravato and ketamine require clinic monitoring for dissociation and BP changes. Your clinician will review risks and monitoring plans.
Will insurance cover them?
Coverage varies: TMS and Spravato are frequently covered with prior authorization when criteria are met; ketamine for depression is usually off-label and often self-pay. Elevium performs pre-treatment benefit checks to clarify costs.
Share Article
If you're considering Spravato and you've done any research, you've probably found a lot of clinical information about how it works in the brain. What's harder to find is a plain-language answer to the more immediate question: What is it actually like to sit through a session? Before You Arrive Spravato is FDA-approved for treatment-resistant depression, meaning it's typically prescribed when at least two antidepressants haven't produced adequate relief. Before your first session, you'll have a consultation and medical screening to confirm you're a suitable candidate. There are some contraindications, so this step matters. A few practical things to sort before each appointment: You can't drive yourself home. Spravato can temporarily affect your perception and alertness, so you're required to have someone pick you up - or arrange another way home. This applies after every session, not just the first one. Don't eat a heavy meal beforehand. Nausea is a possible side effect, and arriving on an empty or light stomach helps. Your clinical team will give you specific guidance on this. Plan your day around it. Each appointment runs for at least two hours - the session itself plus the mandatory monitoring period afterwards. Don't schedule anything demanding immediately after.
Most people have heard of TMS. Fewer know that there's a version that works in a fraction of the time. Standard TMS treatment runs across eight weeks, five sessions a week for six weeks, then a two-week taper. That's up to 36 appointments. For many patients, that schedule is manageable. For others, it isn't, whether because of work, family, geography, or just the practical reality of needing relief faster. One-Day TMS (also called accelerated TMS) was designed for patients like these. Is One-Day TMS? One-Day TMS is an intensive version of standard TMS that condenses the full treatment course into five days, with ten sessions delivered each day. The underlying therapy is identical. The same FDA-cleared technology. The same electromagnetic pulses targeting the same brain networks, the same clinical oversight. What's different is the schedule, and for the right candidate, that difference matters a great deal. At Elevium Health, we use the Magstim Horizon 3.0 Pro with StimGuide+ for all TMS treatments, including the accelerated protocol. This system uses stereotactic neuronavigation to map each patient's brain structure individually, so stimulation is consistently delivered to the correct location, session after session, day after day.
Medication management is one of the most common (and most misunderstood) services in psychiatric care. It's not just being handed a prescription. Done properly, it's an ongoing clinical relationship built around finding the right medication, at the right dose, with the right support around it, and it's one of the core services we offer at Elevium Health in New Jersey. What Is Medication Management? Medication management is the process of prescribing, monitoring, and adjusting psychiatric medication over time. A psychiatrist doesn't just write a prescription and send you on your way; they review your full history, assess your symptom profile, select the most appropriate medication for your presentation, and then track how you respond. The goal is to find an approach that produces meaningful symptom relief while keeping side effects manageable. That often takes some adjustment. Medications affect people differently, and finding the right fit is rarely a first-attempt certainty. At Elevium, medication management is offered as both a standalone service and as part of a broader treatment plan that may include TMS, Spravato, ketamine therapy, or psychotherapy. Who Is Medication Management For? Medication management is suitable for a wide range of presentations. At Elevium, our psychiatrists work with patients experiencing: Depression Anxiety and social anxiety Bipolar disorder OCD ADHD PTSD and trauma-related disorders Stress and adjustment difficulties Grief and loss Learn More: Compare Treatments It's appropriate for people starting psychiatric medication for the first time, those who have been on medication for years but want more active oversight, and those transitioning between medications or managing complex regimens. It's also worth considering if you're already in therapy or receiving another treatment like TMS and want to explore whether medication could complement what you're doing. How Appointments Work at Elevium Initial consultation The first appointment is about building a full picture. Your psychiatrist will review your medical and psychiatric history, go through any medications you've tried before, understand your current symptoms and how they're affecting your life, and identify any risk factors that might influence which medications are appropriate for you. From that, a treatment plan is developed, including a recommended medication, starting dose, and a follow-up schedule. Sessions are available in-office or via telehealth, giving you flexibility around your schedule. Starting medication Once you begin, you'll receive clear guidance on what the medication does , how long it typically takes to work, and what side effects to watch for. Most psychiatric medications (antidepressants in particular) take several weeks before their full effect becomes apparent. Your psychiatrist will set realistic expectations from the start so you know what the timeline looks like. Follow-up appointments Regular follow-ups are built into the process. These appointments exist to track your progress, check for side effects, and make adjustments where needed. If a medication isn't working as hoped, or if side effects are affecting your quality of life, your psychiatrist will work with you to modify the dose or switch to a different option. Over time, as your symptoms stabilise, the frequency of visits typically reduces, shifting to quarterly or bi-annual check-ins once things are well managed. What If the First Medication Doesn't Work? It's common, and it's expected. Finding the right medication for a given person isn't always straightforward. Different drug classes work through different mechanisms, and individual responses vary considerably based on genetics, history, and other health factors. If a first medication doesn't produce the desired effect (or causes intolerable side effects), your psychiatrist will reassess and recommend an alternative. This trial-and-adjustment process is normal clinical practice, not a sign that medication isn't going to work for you. For patients who have already tried multiple antidepressants without adequate relief, Elevium offers TMS and Spravato as evidence-based options specifically designed for treatment-resistant presentations.
If you're searching for a psychiatrist in Florham Park or the surrounding New Jersey area, you'll find no shortage of options. What sets practices apart is the range of treatments they offer, the calibre of the clinical team, and how they approach care. Who We Are Elevium Health is a psychiatric practice based in Florham Park, NJ, founded by two board-certified psychiatrists with more than 38 years of combined experience. The practice was built around a specific belief: that effective psychiatric care means going beyond conventional medication and talk therapy to offer the full range of evidence-based treatments, including advanced neuromodulation therapies that many practices simply don't provide. The clinical team includes: Dr Ritesha Krishnappa, MD, FAPA , a board-certified psychiatrist and Fellow of the American Psychiatric Association. Before co-founding Elevium, Dr Krishnappa served as Interim Medical Director of a New Jersey State Hospital and as Associate Director of Psychiatry at a major New York City community hospital. He has also served as Associate Training Program Director for a psychiatry residency programme. At Elevium, he specialises in TMS, Spravato, and ketamine therapy alongside traditional medication management, and has completed specialised training in TMS and ketamine-assisted psychotherapy. Dr Leena Rajagopal, MD, FAPA, is double-board-certified in General Adult Psychiatry and Forensic Psychiatry, and a Fellow of the American Psychiatric Association. Dr Rajagopal completed her psychiatry residency at the Icahn School of Medicine at Mount Sinai, where she was selected as chief resident, followed by a forensic psychiatry fellowship at Albert Einstein College of Medicine. She previously served as Director of Forensic Services at NYC Health + Hospitals, Elmhurst. At Elevium, she integrates advanced treatments including TMS, Spravato, and ketamine, with a deeply patient-centred approach to care. Both physicians have completed specialised training in TMS and ketamine therapy, and the practice is a REMS-certified Spravato treatment centre. What Treatments Are Available Elevium offers a broader treatment menu than most local psychiatric practices. Depending on your presentation and goals, your care may involve one or more of the following: Transcranial Magnetic Stimulation (TMS) a non-invasive, FDA-approved brain stimulation therapy for treatment-resistant depression, anxious depression, and OCD. TMS uses targeted electromagnetic pulses to modulate activity in specific brain regions. It's delivered in outpatient sessions, requires no anaesthesia, and patients can drive themselves home afterwards. Elevium uses the Magstim Horizon 3.0 Pro with StimGuide+, a system that uses stereotactic neuronavigation to map each patient's brain individually, improving precision and outcomes. We also offer One-Day TMS, an accelerated five-day protocol for patients who can't commit to a standard eight-week schedule. Spravato (Esketamine) - an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. Administered in-clinic under supervision with a two-hour monitoring period. Elevium is a REMS-certified treatment centre, a requirement for offering Spravato. Ketamine Therapy - available via IV, IM, or oral routes for patients with treatment-resistant depression. Not FDA-approved for psychiatric use but supported by a strong and growing body of clinical evidence. Medication Management - personalised psychiatric prescribing with ongoing monitoring , dose adjustments, and follow-up. Available in-office and via telehealth. Psychotherapy - CBT and DBT are the primary modalities offered, alongside interpersonal therapy and person-centred therapy . Therapy is available as a standalone service or in combination with other treatments.
“I went in with OCD symptoms, and after treatment I’m feeling much better… the staff was wonderful - I highly recommend the crew at Elevium.” Joe K., former patient When someone with obsessive-compulsive disorder (OCD) finds a treatment that improves day-to-day life, their story becomes a helpful roadmap for others. Joe K.’s short, honest testimonial does exactly that: it shows what clinical progress looks like and reminds us that compassionate care matters just as much as effective treatment. Below, we use Joe’s experience as a human anchor to explain how Transcranial Magnetic Stimulation (TMS) is used for OCD, what a typical program involves, and practical advice for people and families thinking about this option. Joe’s Experience in His Own Words Joe came to Elevium seeking relief from OCD symptoms. His report is straightforward: after a course of TMS, he felt meaningful improvement, and he was impressed with the clinic team’s care and professionalism. That combination -measurable symptom change plus strong clinical support — is what many patients say makes treatment successful. (Source: Joe’s testimonial.) A clinician’s View: Why TMS Can Help OCD TMS is a non-invasive therapy that uses focused magnetic pulses to influence brain circuits tied to mood, intrusive thoughts, and compulsive behaviors. While TMS is widely used for depression, specialized protocols target cortical and cortico-striatal pathways involved in OCD. Clinical teams deliver tailored stimulation patterns to reduce the intensity and frequency of intrusive thoughts and compulsions. Elevium’s approach follows the evidence-based protocols clinicians use for OCD and integrates careful monitoring throughout treatment. What a Typical TMS Program for OCD Looks Like Although protocols differ between centers, an OCD-focused TMS program commonly includes: Initial evaluation. A comprehensive clinical assessment (psychiatric history, medical screening, medication review) to confirm candidacy and rule out safety concerns. Daily sessions. Most programs provide daily outpatient sessions five days per week over several weeks; each session usually takes 20–40 minutes. Ongoing monitoring. Clinicians track symptom changes and side effects and adjust the protocol as needed. Integrated aftercare. Outcomes improve when TMS is combined with psychotherapy (CBT) or medication management , and some patients later receive booster sessions to maintain gains. Joe’s story emphasizes the team element - staff who support scheduling, answer questions, and help patients manage the logistics of daily treatment. That practical support reduces drop-out and improves real-world outcomes. What the Evidence Says Research and clinical experience show that when OCD-specific TMS targets are used, a meaningful percentage of patients - particularly those who have not responded fully to medication and therapy — experience reductions in intrusive thoughts and compulsions. Results vary by individual, but combining TMS with evidence-based psychotherapy produces greater, longer-lasting improvements in many cases.
A first consultation for Transcranial Magnetic Stimulation (TMS) or ketamine therapy is an important conversation - not just about the treatment itself, but about your goals, safety, logistics, and costs. Use this 20-item checklist to make the most of your visit. For each question below, we explain why it matters and what a clear answer might sound like. Questions about eligibility & clinical fit Am I a good candidate for this treatment? Why: Candidacy depends on diagnosis, treatment history and medical risks. What to expect: The clinician should review your psychiatric and medical history and explain why TMS or ketamine is (or isn’t) appropriate. What evidence supports this treatment for my condition? Why: You should hear about clinical outcomes and the strength of evidence for your diagnosis. Good answer: A clinician references studies or guidelines, and explains expected response rates and what success looks like for your condition. Have I tried other recommended treatments first? Why: Many protocols call for prior trials of therapy/medication before advanced options. What to expect: A review of past medications, psychotherapy, and reasons you’re considering TMS/ketamine now. Are there medical risks or reasons I should not receive treatment? Why: Safety screening (seizure risk, implants, cardiovascular issues) is critical. Good answer: The team will ask focused medical questions and describe contraindications and monitoring plans. How do you determine the exact protocol (dose, number of sessions)? Why: Protocols differ ( standard vs accelerated TMS ; oral/IM/IV ketamine). You should understand selection logic. What to expect: Clinicians explain motor threshold testing (TMS), session frequency, or ketamine route and dosing rationale. Will I need anything else alongside this treatment (therapy, meds)? Why: Combining TMS or ketamine with psychotherapy or medication often improves outcomes. Good answer: A recommendation for follow-up therapy (often CBT) or medication adjustments as part of a treatment plan.
Quick Answer Accelerated TMS - typically delivered with condensed iTBS protocols that allow multiple short sessions per day - is best for people who need faster symptom relief, can’t commit to a 4–6 week schedule, or are willing to travel for a focused treatment week. It’s a safe, evidence-based option for many people with treatment-resistant depression and certain other conditions, but candidacy requires a careful clinical evaluation and screening. What is Accelerated TMS (briefly)? Accelerated TMS uses established TMS technology (magnetic pulses to stimulate brain circuits) but delivers multiple short sessions per day instead of one session daily over many weeks. The most common accelerated approach uses iTBS (intermittent theta-burst stimulation) — sessions are very short (often 3–10 minutes), and a full course can be completed in days rather than weeks. Some accelerated programs deliver ~10 sessions per day × 5 days (≈50 sessions total), though exact protocols vary by clinic and patient. How does it work (in plain language)? TMS targets brain regions involved in mood regulation ( usually the left dorsolateral prefrontal cortex for depression ) using a magnetic coil placed against the scalp. iTBS delivers rapid bursts of stimulation that are thought to induce neuroplastic changes faster than standard repetitive TMS (rTMS). The logistics differ — accelerated protocols schedule several short sessions with breaks during a single clinic day, repeated for a condensed course. Clinically, safety and motor-threshold calibration are performed for every patient to ensure correct dosing. Who’s a good candidate for accelerated TMS? Good candidates often include people who: Have major depressive disorder that hasn’t responded adequately to one or more antidepressant trials and psychotherapy (treatment-resistant depression). Need rapid treatment due to life constraints (work, caregiving) and cannot commit to daily sessions for 4–6 weeks. Prefer a non-systemic option (no sedation or systemic medication side effects) or can’t tolerate antidepressant side effects. Can attend multiple short sessions in a single day (physically and logistically) or are willing to travel and stay near the clinic for the week. Want discreet care — executives and high-profile patients who value private scheduling and billing often choose accelerated protocols paired with concierge services. Who may be especially suited to travel for accelerated TMS: NYC commuters who can’t take weeks off but can plan a single intensive week. Out-of-state patients seeking clinics with extensive accelerated experience. Professionals and executives seeking privacy and concierge scheduling. Elevium’s destination & concierge workflows were developed to support these patients.
Quick overview Your first TMS visit is an important step — and a little preparation makes it smooth. This guide walks you through exactly what to do before, on the day of, and after your first Transcranial Magnetic Stimulation (TMS) session so you arrive prepared, reduce anxiety, and speed your path to care. If you’re traveling or want private scheduling, see the concierge note at the end. Complete your intake BEFORE you arrive (do this first) Finish the forms in the Tebra Patient Portal. This is the fastest way to upload medication lists, records, consent forms, and any questionnaires the clinic uses. Elevium puts the Tebra link in the top navigation — please use it before you visit speed screening and check-in. Send recent records. Upload recent psychiatric notes, medication lists (dose & dates), and any relevant lab results or imaging. If you don’t have records, ask your prior clinician for a summary. Complete a telehealth pre-screen (if offered). Many clinics do a brief tele-visit to review history and answer questions before in-person titration. Confirm medical screening & clearance Seizure & implant screening. TMS requires a safety review for seizure history and intracranial metal/implants. Be honest about any prior seizures, head trauma, or metal hardware. Seizures are rare with proper screening and protocol adherence. Medication review. Bring a full list of current medications (including OTC and supplements). Some meds affect seizure threshold and may require temporary adjustment. Your prescribing clinician will advise. Medical clearance (if needed). If you have cardiac issues, uncontrolled hypertension, or other complex medical conditions, your clinic may request clearance from your PCP or cardiologist. Practical checklist - what to bring Photo ID and insurance card (if using insurance). A printed or digital medication list (drug name, dose, frequency). Completed intake forms from the Tebra Patient Portal (bring confirmation or screen shot). Comfortable, layered clothing (temperature in clinics varies). Snacks and a water bottle for between sessions. Phone charger, headphones, or reading material for breaks. Emergency contact/escort info if your clinic recommends it (most TMS do not require a driver, but check clinic guidance). What to expect on your first session (timeline) Arrival & check-in (10–20 minutes) Sign the consent forms (if not completed), confirm your medical history, and have vitals taken. Psychiatric intake & consent review (30–60 minutes) A clinician reviews diagnosis, meds, benefits/risks, and answers questions. Motor threshold titration (30–60 minutes) A short calibration procedure finds the appropriate stimulation intensity for you. This ensures dosing is safe and personalized. First stimulation block (varies, often <30 minutes) You’ll experience tapping on the scalp. Technicians monitor your comfort frequently. Headache or scalp discomfort can occur and usually improves. Post-session check & scheduling (10–15 minutes) Clinician reviews how you felt and schedules follow-ups. For accelerated programs, you’ll get the daily schedule for upcoming sessions.
Quick answer TMS - a non-invasive brain stimulation therapy - is an emerging, evidence-based option for some anxiety disorders, especially when anxiety appears with depression or is resistant to standard treatments. Protocols vary (standard rTMS, iTBS, and device-specific approaches), and candidacy depends on diagnosis, prior treatment history, and medical safety screening. Elevium offers TMS as part of an integrated plan that pairs neuromodulation with psychotherapy and medication management when appropriate. What the evidence says (short) Research on TMS for anxiety disorders is growing. Clinical trials and real-world studies show promising improvements for generalized anxiety disorder (GAD), panic disorder, and anxiety that co-occurs with depression . Outcomes vary by diagnosis, treatment history, and the specific TMS protocol used. Unlike the large evidence base for TMS in major depressive disorder, anxiety research is more heterogeneous - but many clinics, including Elevium, consider TMS a reasonable next step when therapy and medications are insufficient. Clinicians track outcomes with validated scales such as the GAD-7 and PHQ-9 to measure change. How TMS is delivered for anxiety (protocols) There’s no single “anxiety protocol” — treatment is individualized. Common approaches include: Standard rTMS : repetitive pulses over the dorsolateral prefrontal cortex (DLPFC) — often used when anxiety co-exists with depression. iTBS (intermittent theta burst stimulation): a shorter, accelerated protocol that delivers bursts of stimulation in minutes rather than half-hour sessions. iTBS can be used in standard or accelerated formats. Device/target variations: Some centers tailor the exact coil position and parameters based on symptoms (for example, left vs right DLPFC targeting or medial prefrontal approaches), particularly when anxiety presents with specific network dysfunction. Device-specific programs (including deep TMS for OCD ) demonstrate that coil geometry and target depth can matter for certain diagnoses. Important: Your clinician chooses the protocol after a detailed evaluation (diagnosis, prior trials, and safety screening) and may combine TMS with psychotherapy (CBT, exposure therapy) or medication management to maximize results. Who is a good candidate? TMS for anxiety is usually considered for people who meet one or more of the following: Persistent or severe anxiety despite adequate trials of psychotherapy (for example, CBT or exposure-based treatments) and medications. Comorbid depression + anxiety, where standard TMS depression protocols can improve both mood and anxious symptoms. Occupational need for non-sedating options (e.g., first responders, safety-sensitive jobs) who want a non-systemic approach to symptom relief. Patients seeking accelerated care (time-limited professionals/commuters or destination patients) who can tolerate intensive schedules. Those who prefer to avoid medication side effects or need an additional option when medications aren’t tolerated. Who may not be a candidate: individuals with uncontrolled seizure disorders, certain intracranial metal implants, or unstable medical conditions. Active psychosis or uncontrolled substance use would also typically require stabilization first. Clinics perform a careful medical and medication review to identify contraindications. Read More: Is TMS Right For Me? Typical patient profiles & examples GAD with partial medication response: A patient with chronic generalized anxiety who improved partially on SSRIs but still has disabling worry may benefit from TMS combined with CBT. Panic disorder with avoidance: When panic persists despite therapy and meds, targeted TMS plus exposure/CBT may reduce physiological reactivity and support behavioral recovery. Comorbid depression + anxiety: Many patients with mixed presentations respond to standard depression-targeted TMS, with concurrent reductions in anxiety symptoms. First responders / safety-sensitive workers: TMS offers a non-systemic path when medications are constrained by duty requirements — Elevium develops return-to-duty plans in coordination with employers and medical officers.
Why this matters First responders and public safety workers face unique clinical and occupational constraints: certain medications can impair alertness or reaction time, and some roles (firefighters, police officers, air-crew) require careful consideration of fitness for duty. TMS is a non-systemic, non-sedating intervention that can be an important treatment option when medication choices are limited by duty requirements. Elevium’s model supports duty-sensitive care, departmental outreach, and return-to-duty planning to help workers recover safely while maintaining public safety. Key clinical advantage: non-systemic option TMS is non-systemic — it does not require daily oral medication and does not carry the same systemic side effects (sedation, slowed reaction time) that can limit occupational fitness. Because TMS stimulates target brain circuits externally , many first responders tolerate it without effects that would interfere with duty. This makes TMS an attractive alternative or adjunct when medications are contraindicated for work reasons. Medication limitations & common duty concerns Many commonly used psychiatric medications may pose challenges for safety-sensitive occupations: Sedative medications (benzodiazepines, sedating hypnotics) can impair judgment, alertness, and motor skills — often disqualifying for duty. Certain antidepressants can cause sedation, orthostatic hypotension, or slowed reaction time in some patients, which requires monitoring. Medications that alter cognition or cause profound fatigue are generally avoided or used with caution in active duty roles. Controlled substances and substances that affect performance may require special workplace policies and monitoring. Because of these constraints, departments often seek non-pharmacologic options or medication regimens that preserve alertness and safety. Elevium’s medication-management team works closely with occupational medical officers to find duty-compatible plans and to document clinical rationale when medications are necessary. Evidence & candidate profiles Who might benefit First responders with major depressive disorder or co-occurring anxiety who either cannot tolerate standard medications or have occupation-related medication restrictions. Workers with treatment-resistant symptoms despite therapy and limited medication options. Personnel seeking a non-sedating, evidence-based treatment option that can be coordinated with employers. Evidence TMS has a robust evidence base for major depressive disorder and growing support for anxiety and other comorbid conditions. While device protocols differ ( standard rTMS, iTBS, deep TMS for specific diagnoses ), many clinics have successfully adapted TMS pathways for duty-sensitive workers with careful screening and coordination. Outcomes are measured with standardized scales, and return-to-duty readiness is evaluated case-by-case. Practical duty considerations & return-to-duty planning Screening & medical clearance Medical and medication review (seizure history, implants, cardiovascular risk). Coordination with occupational medicine or department medical officers for fitness-for-duty assessment. On-treatment monitoring TMS requires no systemic anesthesia; most patients resume normal activity after sessions. Clinicians still evaluate fatigue or headaches that may temporarily affect duty readiness. For accelerated protocols (condensed schedules), plan for potential short-term fatigue during the treatment week. Departments may prefer light duty for intensive days. Return-to-duty steps Documented clinical improvement using validated scales (PHQ-9, GAD-7, CGI). Occupational assessment by department medical officer, incorporating clinician notes and functional status. Stepwise clearance — phased or modified duty as needed (e.g., limited-field assignments, no heavy equipment) with re-evaluation intervals. Maintenance & follow-up — booster TMS sessions or ongoing psychotherapy/medication as clinically indicated. Elevium develops return-to-duty plans in partnership with departments to balance recovery and public safety. Alternatives & complementary pathways Standard TMS (daily sessions over weeks) — useful when time allows and for stable schedules. Accelerated TMS / iTBS — condensed options for time-limited workers or destination patients; requires planning for daily onsite time and possible short-term fatigue. Psychotherapy (CBT/ERP) — essential for anxiety/PTSD and to consolidate gains from TMS. Careful medication strategies — where medications are necessary, choice and dosing are customized to minimize duty impairment; occupational restrictions are explicitly addressed. Spravato / ketamine — these options can have rapid effects but require in-clinic monitoring (Spravato REMS — ≥2 hours observation) or may cause dissociation; they may be unsuitable for immediate return to duty and often require careful clearance.
